Loading...
XSTOEPISb
Market cap6mUSD
Dec 23, Last price  
0.12SEK
1D
-3.61%
1Q
-21.63%
Jan 2017
-98.97%
IPO
-99.76%
Name

Episurf Medical AB

Chart & Performance

D1W1MN
XSTO:EPISb chart
P/E
—
P/S
7.42
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
51.24%
Rev. gr., 5y
20.82%
Revenues
10m
+56.06%
000037,916173,0261,016,4622,405,6142,490,2484,000,0004,900,0005,000,0006,500,0006,600,00010,300,000
Net income
-95m
L+22.64%
-540,241-2,786,253-4,458,653-15,769,779-22,856,694-32,914,421-43,974,662-61,667,464-61,093,452-57,800,000-70,600,000-64,600,000-69,500,000-77,300,000-94,800,000
CFO
-85m
L+22.01%
-1,998,651-3,913,785-15,045,172-20,642,962-31,659,426-38,039,032-56,096,044-61,381,599-52,300,000-59,200,000-54,100,000-59,700,000-69,500,000-84,800,000
Earnings
Feb 07, 2025

Profile

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
URL
https://episurf.com/
IPO date
Nov 05, 2010
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,300
56.06%
6,600
1.54%
6,500
30.00%
Cost of revenue
107,100
15,800
(2,100)
Unusual Expense (Income)
NOPBT
(96,800)
(9,200)
8,600
NOPBT Margin
132.31%
Operating Taxes
200
100
300
Tax Rate
3.49%
NOPAT
(97,000)
(9,300)
8,300
Net income
(94,800)
22.64%
(77,300)
11.22%
(69,500)
7.59%
Dividends
Dividend yield
Proceeds from repurchase of equity
200
500
151,600
BB yield
-0.08%
-0.08%
-14.70%
Debt
Debt current
2,900
2,500
2,100
Long-term debt
7,500
10,100
3,700
Deferred revenue
Other long-term liabilities
100
1,000
2,800
Net debt
(47,500)
(142,700)
(232,100)
Cash flow
Cash from operating activities
(84,800)
(69,500)
(59,700)
CAPEX
(11,300)
(7,000)
Cash from investing activities
(9,500)
(11,200)
(6,500)
Cash from financing activities
(3,000)
(1,900)
149,200
FCF
(95,700)
(13,000)
8,900
Balance
Cash
57,900
155,300
237,900
Long term investments
Excess cash
57,385
154,970
237,575
Stockholders' equity
(600,000)
(506,900)
(431,300)
Invested Capital
689,800
691,900
689,800
ROIC
1.34%
ROCE
3.33%
EV
Common stock shares outstanding
266,997
266,627
226,594
Price
0.99
-57.87%
2.35
-48.35%
4.55
50.17%
Market cap
264,327
-57.81%
626,574
-39.23%
1,031,001
109.94%
EV
216,827
484,074
799,201
EBITDA
(90,800)
(1,800)
16,000
EV/EBITDA
49.95
Interest
900
700
200
Interest/NOPBT
2.33%